Wednesday's Electric Car Stocks Trading; (AONE), (HEV), (TSLA), (OTCBB: EVCA)
Point Roberts, WA - October 13, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in cleantech investor research, reports on electric car stocks trading and news for 12th October.
A123 Systems, Inc. (NASDAQ:AONE) was the biggest gainer and jumped 0.88 (26.59%) to $4.19 after the company said that it has been selected General Motors to supply power as the company has decided to sell an all-electric Chevrolet small car for the U.S. market by 2013
General Motors Company (NYSE:GM) shares soared 0.91 (4.04%) to close at $23.41.
Ener1, Inc. (NASDAQ:HEV) rose 0.025 (9.43%), rebounding from its recent lows on high volume. The stock has recovered 200% from its 52-week low of $0.09, made late September.
T3 Motion, Inc. (AMEX:TTTM) added 0.070 (8.24%) to $0.92 after it announced that the Kuwaiti Ministry of the Interior has placed additional orders bringing the total deployment in Kuwait to $448,000 for T3 Electric Stand-up Vehicles (ESV).
Evcarco Inc (OTC:EVCA) ended with gains of 0.0004 (44.44%) at $0.0013, rebounding from its recent lows.
Eaton Corporation (NYSE:ETN) gained 1.06 (2.62%) to $41.55. The Company reported Tuesday that customers of its hybrid systems have collectively accumulated more than 200 million miles of service, reducing diesel fuel consumption by 8 million gallons and harmful emissions by 80,000 metric tons.
Tesla Motors, Inc . (NASDAQ: TSLA) gained 0.19 (0.69%) to close at $27.80.
Electric Car/ Green Car Company Snapshot :
EVCARCO (OTC.BB: EVCA) - Green, Electric Cars and Natural Gas Vehicles
EVCARCO (OTC.BB:EVCA) (www.evcarco.com) is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles.
Visit the EVCA profile at Investorideas.com - http://www.investorideas.com/CO/EVCA/
Research electric car stocks and green auto stocks, lithium stocks - with the renewable energy stocks directory Research over 1300 green stocks - Investors also have the option to access the directory as part of the Investor Ideas Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 10 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit our green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or
www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks on Facebook.com
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. Disclosure: Investorideas is compensated by featured green companies EVCARCO (OTCBB: EVCA) is a showcase stock at Investorideas.com and compensated the site 500,000 144 shares in lieu of cash compensation.
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information contact:
800 665 0411
Source: www.Investorideas.com
Thursday, October 13, 2011
Wednesday's NASDAQ Top Percentage Gainers: PACB, HOGS, GTIV, WVFC
POINT ROBERTS - October 13, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Wednesday October 12th. Nasdaq closed higher by 21.70 (0.84%) at 2,604.73.
Pacific Biosciences of California (NASDAQ:PACB) was the top percentage gainer for the day closing higher 0.87 (28.16%), following a 20% fall in the previous week. The stock also closed well above its 200-day moving average on high volume. The company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and proteins. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT®, technology.
ZHONGPIN INC. (NASDAQ:HOGS) surged 1.26 (18.83%) to close at $7.95, rebounding from its 52-week low of $6.60, made earlier this week. The stock had strong recovery in yesterday's trading , moving within a broader range of $6.88-$8.18 during the session. The stock is trading up again in this morning's trading.
Gentiva Health Services, Inc. (NASDAQ:GTIV) closed with a gain of 0.66 (17.19%) to end the day at $4.50, bouncing back from its recent low. The stock has been showing strong support around $3.50 level. More than 3.80 million shares exchanged hands. The stock has a 52-week range of $2.81-$29.21.
WVS Financial Corp. (NASDAQ:WVFC) moved higher by 1.83 (21.25%) to $10.44, rebounding from recent low. WVS Financial Corp. (WVS) is the parent holding company of West View Savings Bank (West View). West View Savings Bank is a Pennsylvania-chartered stock savings bank conducting business from six offices in the North Hills suburbs of Pittsburgh.
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/ Disclaimer.asp
800-665-0411
Source www.Investorideas.com
POINT ROBERTS - October 13, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Wednesday October 12th. Nasdaq closed higher by 21.70 (0.84%) at 2,604.73.
Pacific Biosciences of California (NASDAQ:PACB) was the top percentage gainer for the day closing higher 0.87 (28.16%), following a 20% fall in the previous week. The stock also closed well above its 200-day moving average on high volume. The company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and proteins. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT®, technology.
ZHONGPIN INC. (NASDAQ:HOGS) surged 1.26 (18.83%) to close at $7.95, rebounding from its 52-week low of $6.60, made earlier this week. The stock had strong recovery in yesterday's trading , moving within a broader range of $6.88-$8.18 during the session. The stock is trading up again in this morning's trading.
Gentiva Health Services, Inc. (NASDAQ:GTIV) closed with a gain of 0.66 (17.19%) to end the day at $4.50, bouncing back from its recent low. The stock has been showing strong support around $3.50 level. More than 3.80 million shares exchanged hands. The stock has a 52-week range of $2.81-$29.21.
WVS Financial Corp. (NASDAQ:WVFC) moved higher by 1.83 (21.25%) to $10.44, rebounding from recent low. WVS Financial Corp. (WVS) is the parent holding company of West View Savings Bank (West View). West View Savings Bank is a Pennsylvania-chartered stock savings bank conducting business from six offices in the North Hills suburbs of Pittsburgh.
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/ Disclaimer.asp
800-665-0411
Source www.Investorideas.com
Wednesday, October 12, 2011
Trending Top Investor Searches: Renewable Energy, Water, Agriculture and Infrastructure Stocks Lead
(NasdaqGS: HEV), (NYSE: BIP), (TSX: ARF), (NYSE:MY) in Top Ten
POINT ROBERTS, October 12 , 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on this weeks trending top ten investor searches.
Renewable energy stocks, water, agriculture and some infrastructure stocks were in the top ten investor searches for the week.
Ener1 Inc (NasdaqGS: HEV ) was the most searched as investors watched the stock make an impressive run for the week. The stock is currently trading at 0.2801, up 0.0151 (5.70%) 2:05PM EDT.
Infrastructure stocks Armtec Infrastructure (Toronto: ARF.TO ) and Brookfield Infrastructure (NYSE: BIP) were also in the top ten. Armtec Infrastructure moved from just over $1.00 to as high as $3.35 on news of a BC Hydro deal. Armtec is currently trading at $2.24.
Wind stock, China Ming Yang Wind Power (NYSE: MY ) is trading at $2.73, up 0.14. (5.41%) 2:03PM EDT
Investorideas.com Top Investor Searches…
1. NASDAQ:HEV
2. NASDAQ:CPST
3. NYSE:BIP
4. Renewable energy stocks
5. Agriculture stocks
6. Water stocks
7. NASDAQ:DRYS
8. Natural gas stocks
9. TSE:ARF
10. NYSE: MY
Investorideas.com Free Investor Tools;
Learn More about Investorideas.com showcase stocks
http://www.investorideas.com/Showcase/
Sign up for the free investor news and stock alerts- water stocks, renewable energy, gold stocks and more
http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Become a Member
Research renewable energy stocks, gold stocks, water stocks, oil and gas and more with the largest stock directories online for investors
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including renewable energy, water and energy stocks. The renewable energy stocks directory features over 1300 green stocks, making it the largest online !
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source – Investorideas.com
800-665-0411
(NasdaqGS: HEV), (NYSE: BIP), (TSX: ARF), (NYSE:MY) in Top Ten
POINT ROBERTS, October 12 , 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on this weeks trending top ten investor searches.
Renewable energy stocks, water, agriculture and some infrastructure stocks were in the top ten investor searches for the week.
Ener1 Inc (NasdaqGS: HEV ) was the most searched as investors watched the stock make an impressive run for the week. The stock is currently trading at 0.2801, up 0.0151 (5.70%) 2:05PM EDT.
Infrastructure stocks Armtec Infrastructure (Toronto: ARF.TO ) and Brookfield Infrastructure (NYSE: BIP) were also in the top ten. Armtec Infrastructure moved from just over $1.00 to as high as $3.35 on news of a BC Hydro deal. Armtec is currently trading at $2.24.
Wind stock, China Ming Yang Wind Power (NYSE: MY ) is trading at $2.73, up 0.14. (5.41%) 2:03PM EDT
Investorideas.com Top Investor Searches…
1. NASDAQ:HEV
2. NASDAQ:CPST
3. NYSE:BIP
4. Renewable energy stocks
5. Agriculture stocks
6. Water stocks
7. NASDAQ:DRYS
8. Natural gas stocks
9. TSE:ARF
10. NYSE: MY
Investorideas.com Free Investor Tools;
Learn More about Investorideas.com showcase stocks
http://www.investorideas.com/Showcase/
Sign up for the free investor news and stock alerts- water stocks, renewable energy, gold stocks and more
http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Become a Member
Research renewable energy stocks, gold stocks, water stocks, oil and gas and more with the largest stock directories online for investors
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including renewable energy, water and energy stocks. The renewable energy stocks directory features over 1300 green stocks, making it the largest online !
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source – Investorideas.com
800-665-0411
Renewable Energy Stocks to Watch; Battery Maker A123 (NASDAQ:AONE) Spikes Over 17% on GM Deal
Point Roberts WA-, October12, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research, releases a trading alert for battery stock, A123 Systems, Inc. (NasdaqGS: AONE ). The stock has jumped as high as $3.97, now trading at $3.90, up 0.59 (17.82%) 12:32pm.
The stock bounced on reports that General Motors will start selling an all-electric Chevrolet small car for the U.S. market by 2013 and will use the A123 Systems batter systems.
General Motors (NYSE: GM ) is also up, trading at $23.50, up 1.00 (4.44%) 12:36pm.
A123 Systems, Inc. develops and manufactures advanced lithium ion batteries and battery systems for the transportation, electric grid services and commercial markets. Headquartered in Massachusetts and founded in 2001, A123's proprietary nanoscale electrode technology is built on initial developments from the Massachusetts Institute of Technology.
Use the renewable energy stocks directory to research 1300 green stocks on global stock exchanges http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com – a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or
www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com is not compensated by AONE
For more information about Investorideas.com contact:
800.665.0411
Point Roberts WA-, October12, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research, releases a trading alert for battery stock, A123 Systems, Inc. (NasdaqGS: AONE ). The stock has jumped as high as $3.97, now trading at $3.90, up 0.59 (17.82%) 12:32pm.
The stock bounced on reports that General Motors will start selling an all-electric Chevrolet small car for the U.S. market by 2013 and will use the A123 Systems batter systems.
General Motors (NYSE: GM ) is also up, trading at $23.50, up 1.00 (4.44%) 12:36pm.
A123 Systems, Inc. develops and manufactures advanced lithium ion batteries and battery systems for the transportation, electric grid services and commercial markets. Headquartered in Massachusetts and founded in 2001, A123's proprietary nanoscale electrode technology is built on initial developments from the Massachusetts Institute of Technology.
Use the renewable energy stocks directory to research 1300 green stocks on global stock exchanges http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com – a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or
www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com is not compensated by AONE
For more information about Investorideas.com contact:
800.665.0411
Junior Oil and Gas Stock Trading Alert: Osage (OTCBB: OEDV) Gaps up 42%
Point Roberts, WA. October 12, 2011 (Investorideas.com Energy Newswire) - www.InvestorIdeas.com, a leader in sector research including oil and gas stocks, issues a trading alert for Osage Exploration and Development, Inc. (OTCBB: OEDV). The stock is trading at $0.50, up 0.15 (42.86%) on light volume in this morning’s trading session.
The stock reached its 52 -week high of $0.62 following news of expanding its acreage on the Mississippian project and has pulled back recently to around $0.30 on low volume as oil prices fell.
The Company reported the following update in September: Osage Exploration and Development, Inc. (OTCBB: OEDV), along with its partners Slawson Exploration Company and U.S. Energy Development Corporation, is pleased to announce that we have been able to continue to increase our net land position to 15,000 acres in the highly prospective area east of the Nemaha Ridge in the Oklahoma horizontal Mississippian play.
Slawson Exploration Company is the Operator of the project and owns 45%, U.S. Energy Development Corporation owns 30%, and Osage Exploration has 25%.
Osage Exploration and Development, Inc. (OTCBB: OEDV)
Based in San Diego, California with production offices in Oklahoma City, Oklahoma, and executive offices in Bogotá, Colombia, Osage Exploration and Development, Inc. is an independent exploration and production company with interests in oil and gas wells and prospects in the US and Colombia. www.osageexploration.com
Follow (OTCBB: OEDV) on Twitter.com
http://twitter.com/#!/OsageOEDV
Visit the Osage (OTCBB: OEDV) company showcase profile at Investorideas.com
http://www.investorideas.com/CO/OEDV/
Request news and trading alerts on OEDV
http://www.investorideas.com/Resources/Newsletter.asp
Research more oil and gas stocks with the oil and gas stock directory at Investorideas.com – lists over 600 stocks including Bakken stocks
http://www.investorideas.com/OGSN/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: OEDV is a paid advertising oil and gas company on Investorideas.com - Disclosure: (6 months starting May 24, 2011 thirty five hundred per month, 100,000 144 shares)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
800-665-0411 - cvanzant@investorideas.com or dawn@investorideas.com
Source - Investorideas.com
Point Roberts, WA. October 12, 2011 (Investorideas.com Energy Newswire) - www.InvestorIdeas.com, a leader in sector research including oil and gas stocks, issues a trading alert for Osage Exploration and Development, Inc. (OTCBB: OEDV). The stock is trading at $0.50, up 0.15 (42.86%) on light volume in this morning’s trading session.
The stock reached its 52 -week high of $0.62 following news of expanding its acreage on the Mississippian project and has pulled back recently to around $0.30 on low volume as oil prices fell.
The Company reported the following update in September: Osage Exploration and Development, Inc. (OTCBB: OEDV), along with its partners Slawson Exploration Company and U.S. Energy Development Corporation, is pleased to announce that we have been able to continue to increase our net land position to 15,000 acres in the highly prospective area east of the Nemaha Ridge in the Oklahoma horizontal Mississippian play.
Slawson Exploration Company is the Operator of the project and owns 45%, U.S. Energy Development Corporation owns 30%, and Osage Exploration has 25%.
Osage Exploration and Development, Inc. (OTCBB: OEDV)
Based in San Diego, California with production offices in Oklahoma City, Oklahoma, and executive offices in Bogotá, Colombia, Osage Exploration and Development, Inc. is an independent exploration and production company with interests in oil and gas wells and prospects in the US and Colombia. www.osageexploration.com
Follow (OTCBB: OEDV) on Twitter.com
http://twitter.com/#!/OsageOEDV
Visit the Osage (OTCBB: OEDV) company showcase profile at Investorideas.com
http://www.investorideas.com/CO/OEDV/
Request news and trading alerts on OEDV
http://www.investorideas.com/Resources/Newsletter.asp
Research more oil and gas stocks with the oil and gas stock directory at Investorideas.com – lists over 600 stocks including Bakken stocks
http://www.investorideas.com/OGSN/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: OEDV is a paid advertising oil and gas company on Investorideas.com - Disclosure: (6 months starting May 24, 2011 thirty five hundred per month, 100,000 144 shares)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
800-665-0411 - cvanzant@investorideas.com or dawn@investorideas.com
Source - Investorideas.com
Tuesday, October 11, 2011
Infrastructure Stock News; Fireman's Contractors (OTCBB: FRCN) Moves Into New Headquarters in Fort Worth
FORT WORTH, Texas - October 11, 2011 (Investorideas.com Newswire) Fireman's Contractors Inc. (OTCBB:FRCN.OB) (OTCQB:FRCN.OB) is a full service contractor providing professional services for commercial and government clients in Road Improvements, Parking Lot Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, and Asphalt Maintenance and Repair has moved into their new corporate offices in Fort Worth, Texas. The relocation from North Richland Hills was spurred by continuous growth within the Company, including customer service, marketing, sales, operational personnel and will allow us to begin our efforts in franchise development.
"We are excited to complete renovations and move into a national corporate space where we can accommodate our growth, expand our services, cultivate our business relationships, develop our franchise system, and enable current and future employees to work efficiently under one roof," stated, Renee Gilmore, CEO of Fireman's Contractors.
New Headquarters:
Fireman's Contractors, Inc.
2406 Gravel Drive
Fort Worth, TX 76118
FIREMAN'S CONTRACTORS Inc. (OTCBB:FRCN.OB) is a full service contractor providing superior service in parking lot maintenance and construction services. Our services include Road Improvements, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, ADA Compliance and other construction services which are delivered at a competitive price. Fireman's brings professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations.
Founded by a Firefighter, Fireman's Contractors -- Contractors You Can Trust (R)
To learn more about Fireman's Contractors, please visit our website: http://www.Firemans-Contractors.com
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
Contact:
FIREMAN'S CONTRACTORS Inc.
2406 Gravel Road
Fort Worth, TX 76118
Phone: 800-475-1479
info@FiremansContractors.com
Investor Relations Contact:
John Pentony, IR Affiliates
Contact: john@iraffiliates.com
Tel: 469.252.3031
Public Relations Contact:
Danielle O'Neal
Contact: PR@FiremansContractors.com
Tel: 800-475-1479
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Twitter.com
http://twitter.com/#!/firemansco
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Facebook.com
http://www.facebook.com/FiremansContractors
FORT WORTH, Texas - October 11, 2011 (Investorideas.com Newswire) Fireman's Contractors Inc. (OTCBB:FRCN.OB) (OTCQB:FRCN.OB) is a full service contractor providing professional services for commercial and government clients in Road Improvements, Parking Lot Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, and Asphalt Maintenance and Repair has moved into their new corporate offices in Fort Worth, Texas. The relocation from North Richland Hills was spurred by continuous growth within the Company, including customer service, marketing, sales, operational personnel and will allow us to begin our efforts in franchise development.
"We are excited to complete renovations and move into a national corporate space where we can accommodate our growth, expand our services, cultivate our business relationships, develop our franchise system, and enable current and future employees to work efficiently under one roof," stated, Renee Gilmore, CEO of Fireman's Contractors.
New Headquarters:
Fireman's Contractors, Inc.
2406 Gravel Drive
Fort Worth, TX 76118
FIREMAN'S CONTRACTORS Inc. (OTCBB:FRCN.OB) is a full service contractor providing superior service in parking lot maintenance and construction services. Our services include Road Improvements, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, ADA Compliance and other construction services which are delivered at a competitive price. Fireman's brings professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations.
Founded by a Firefighter, Fireman's Contractors -- Contractors You Can Trust (R)
To learn more about Fireman's Contractors, please visit our website: http://www.Firemans-Contractors.com
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
Contact:
FIREMAN'S CONTRACTORS Inc.
2406 Gravel Road
Fort Worth, TX 76118
Phone: 800-475-1479
info@FiremansContractors.com
Investor Relations Contact:
John Pentony, IR Affiliates
Contact: john@iraffiliates.com
Tel: 469.252.3031
Public Relations Contact:
Danielle O'Neal
Contact: PR@FiremansContractors.com
Tel: 800-475-1479
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Twitter.com
http://twitter.com/#!/firemansco
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Facebook.com
http://www.facebook.com/FiremansContractors
Fireman's Contractors Inc. (OTCBB:FRCN), (OTCQB:FRCN.OB) is a featured construction stock on Investorideas.com
Visit the company profile to learn more: http://www.investorideas.com/CO/FRCN/
Disclaimer/ Disclosure: FRCN has compensated Investorideas.com ten thousand for three months of advertising. All info published is sourced from public files or the Company. This is not a solicitation go buy or sell securities.
Monday's NASDAQ Top Percentage Gainers: AMCF, DLGC, ANTH, CETV
POINT ROBERTS - October 11, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday October 10th. NASDAQ closed significantly higher by 86.70 (3.50%) at 2,566.05.
Andatee China Marine Fuel Services (NASDAQ:AMCF) was the top percentage gainer for the session closing higher by 0.90 (37.50%) to $3.30 extending its 31% rally on Friday. On Friday, the company said that a jury in the District Court for the Eastern District of Michigan has determined that the company does not infringe on IMRA America's patent number 5,818,630 in a suit originally brought by IMRA in 2006.
Dialogic Inc (NASDAQ:DLGC) surged 0.50 (25.13%) to close at $2.49, extending its weekly rally to 35%. The stock has shown nice bounce back from its recent low on high volume.
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) closed with a notable gain of 0.87 (17.98%) to end the day at $5.71, bouncing back from its recent low. The stock has been showing strong support around $4.50 level. More than 101K shares exchanged hands. The stock has a 52-week range of $3.65-$9.08.
Central European Media Enterprises (NASDAQ:CETV) continued to moved higher by 1.42 (17.07%) to $9.74. The stock has soared over 25% in the past week, after hitting a new 52-week low of $6.54 last week.
Investor Ideas Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Stock alerts and trading ideas
Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
POINT ROBERTS - October 11, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday October 10th. NASDAQ closed significantly higher by 86.70 (3.50%) at 2,566.05.
Andatee China Marine Fuel Services (NASDAQ:AMCF) was the top percentage gainer for the session closing higher by 0.90 (37.50%) to $3.30 extending its 31% rally on Friday. On Friday, the company said that a jury in the District Court for the Eastern District of Michigan has determined that the company does not infringe on IMRA America's patent number 5,818,630 in a suit originally brought by IMRA in 2006.
Dialogic Inc (NASDAQ:DLGC) surged 0.50 (25.13%) to close at $2.49, extending its weekly rally to 35%. The stock has shown nice bounce back from its recent low on high volume.
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) closed with a notable gain of 0.87 (17.98%) to end the day at $5.71, bouncing back from its recent low. The stock has been showing strong support around $4.50 level. More than 101K shares exchanged hands. The stock has a 52-week range of $3.65-$9.08.
Central European Media Enterprises (NASDAQ:CETV) continued to moved higher by 1.42 (17.07%) to $9.74. The stock has soared over 25% in the past week, after hitting a new 52-week low of $6.54 last week.
Investor Ideas Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Stock alerts and trading ideas
Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
Biotech/Pharma stocks News; BioSante Pharmaceuticals (NASDAQ
: BPAX) Reports Positive LibiGel® Safety Data Review in Phase III Program
LINCOLNSHIRE, Ill. - October 11, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX), announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects. The independent DMC has recommended that the LibiGel safety study should continue as per the FDA-agreed protocol, without modifications. LibiGel (testosterone gel) is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
BioSante reported that with 3,656 women enrolled and over 4,800 women-years of exposure in its LibiGel Phase III cardiovascular and breast cancer safety study, there have been 29 adjudicated cardiovascular (CV) events, with a lower than anticipated event rate of approximately 0.60 percent. In the same population of subjects, there have been 17 breast cancers reported, a rate of approximately 0.35 percent, which is in line with the ages of the subjects enrolled in the study.
"The DMC once again has recommended that the safety study continue as per the FDA-agreed protocol, without modification as there were no general or specific safety issues based on their unblinded review of adverse events. We are pleased that the low number of CV events to date is consistent with the safety of testosterone in this population," stated Michael Snabes, M.D., Ph.D., the senior vice president of medical affairs for BioSante. "The enrollment of 3,656 subjects was completed in June 2011, and the primary safety analysis will be conducted and reported in the third quarter of 2012. This analysis will allow us to submit the LibiGel new drug application (NDA) in the fourth quarter of 2012, as planned."
Subjects have been enrolled in this study for an average of 15.7 months. More than 2,000 subjects have been enrolled in the study for more than a year and over 770 subjects have been enrolled for more than two years. The periodic reviews by the DMC are based on their mandate in accordance with FDA agreement on protocol-defined study oversight.
"LibiGel remains the only product in the world in Phase III clinical development for the treatment of HSDD," said Stephen M. Simes, BioSante�s president & CEO. "With this most recent favorable DMC recommendation, we continue to believe that LibiGel will be the first product approved by the FDA to treat HSDD, also referred to as FSD, in menopausal women."
About the LibiGel Phase III Cardiovascular and Breast Cancer Safety Study
The Phase III LibiGel safety study is a randomized, double-blind, placebo-controlled, multi-center, cardiovascular (CV) events and breast cancer study that has completed enrollment of 3,656 subjects. The study will continue for a total of five years, however, BioSante can use the safety study data as part of an NDA submission after the last subject enrolled has completed 12 months of exposure to LibiGel or placebo.
The LibiGel safety study is tracking a predefined list of CV events, in agreement with the FDA, including CV death, myocardial infarction and stroke in women 50 years of age or older and suffering from at least two CV risk factors including hypertension and diabetes. The objective of the safety study is to show the relative safety of testosterone compared to placebo in the number of CV events. The incidence of breast cancer also is being tracked over the course of the study. The study represents the largest data base of the safety of testosterone in women.
Upon completion of the statistical analyses of the safety study and efficacy trials, BioSante intends to submit an NDA to the FDA, requesting approval to market LibiGel for the treatment of HSDD in menopausal women.
About LibiGel®
LibiGel is a testosterone gel in Phase III clinical development for the treatment of women who suffer from female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD). The completed Phase III efficacy trials are double-blind, placebo-controlled trials that enrolled over 500 surgically menopausal women each for six-months of therapy. The completed efficacy trials were conducted under an FDA-agreed special protocol assessment (SPA) agreement. LibiGel is absorbed quickly through the skin after applying a once-daily pea-sized topical application on the upper arm that delivers testosterone to the bloodstream evenly over time.
In a Phase II trial, LibiGel significantly increased the number of satisfying sexual events in surgically menopausal women suffering from FSD by 238 percent versus baseline (p<0.0001); this increase also was significant versus placebo (p<0.05). In this study, the effective dose of LibiGel produced testosterone blood levels within the normal range for pre-menopausal women and had a safety profile similar to that observed in the placebo group. In addition, no serious adverse events and no discontinuations due to adverse events occurred in any subject receiving LibiGel. The Phase II clinical trial was a double-blind, placebo-controlled trial, conducted in the UnitedStates , in surgically menopausal women distressed by their low sexual desire and activity.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to its future operations and products, the timing of anticipated clinical development milestones and regulatory submissions and other statements identified by words such as "anticipates," "expects," "will," "continue," "could," "believes," "intends," "estimates," "may," other words of similar meaning, derivations of such words and the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
Harris D. McKinney, Inc.
Alan Zachary, 312-506-5220
azachary@harrisdmckinney.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com
LINCOLNSHIRE, Ill. - October 11, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX), announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects. The independent DMC has recommended that the LibiGel safety study should continue as per the FDA-agreed protocol, without modifications. LibiGel (testosterone gel) is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
BioSante reported that with 3,656 women enrolled and over 4,800 women-years of exposure in its LibiGel Phase III cardiovascular and breast cancer safety study, there have been 29 adjudicated cardiovascular (CV) events, with a lower than anticipated event rate of approximately 0.60 percent. In the same population of subjects, there have been 17 breast cancers reported, a rate of approximately 0.35 percent, which is in line with the ages of the subjects enrolled in the study.
"The DMC once again has recommended that the safety study continue as per the FDA-agreed protocol, without modification as there were no general or specific safety issues based on their unblinded review of adverse events. We are pleased that the low number of CV events to date is consistent with the safety of testosterone in this population," stated Michael Snabes, M.D., Ph.D., the senior vice president of medical affairs for BioSante. "The enrollment of 3,656 subjects was completed in June 2011, and the primary safety analysis will be conducted and reported in the third quarter of 2012. This analysis will allow us to submit the LibiGel new drug application (NDA) in the fourth quarter of 2012, as planned."
Subjects have been enrolled in this study for an average of 15.7 months. More than 2,000 subjects have been enrolled in the study for more than a year and over 770 subjects have been enrolled for more than two years. The periodic reviews by the DMC are based on their mandate in accordance with FDA agreement on protocol-defined study oversight.
"LibiGel remains the only product in the world in Phase III clinical development for the treatment of HSDD," said Stephen M. Simes, BioSante�s president & CEO. "With this most recent favorable DMC recommendation, we continue to believe that LibiGel will be the first product approved by the FDA to treat HSDD, also referred to as FSD, in menopausal women."
About the LibiGel Phase III Cardiovascular and Breast Cancer Safety Study
The Phase III LibiGel safety study is a randomized, double-blind, placebo-controlled, multi-center, cardiovascular (CV) events and breast cancer study that has completed enrollment of 3,656 subjects. The study will continue for a total of five years, however, BioSante can use the safety study data as part of an NDA submission after the last subject enrolled has completed 12 months of exposure to LibiGel or placebo.
The LibiGel safety study is tracking a predefined list of CV events, in agreement with the FDA, including CV death, myocardial infarction and stroke in women 50 years of age or older and suffering from at least two CV risk factors including hypertension and diabetes. The objective of the safety study is to show the relative safety of testosterone compared to placebo in the number of CV events. The incidence of breast cancer also is being tracked over the course of the study. The study represents the largest data base of the safety of testosterone in women.
Upon completion of the statistical analyses of the safety study and efficacy trials, BioSante intends to submit an NDA to the FDA, requesting approval to market LibiGel for the treatment of HSDD in menopausal women.
About LibiGel®
LibiGel is a testosterone gel in Phase III clinical development for the treatment of women who suffer from female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD). The completed Phase III efficacy trials are double-blind, placebo-controlled trials that enrolled over 500 surgically menopausal women each for six-months of therapy. The completed efficacy trials were conducted under an FDA-agreed special protocol assessment (SPA) agreement. LibiGel is absorbed quickly through the skin after applying a once-daily pea-sized topical application on the upper arm that delivers testosterone to the bloodstream evenly over time.
In a Phase II trial, LibiGel significantly increased the number of satisfying sexual events in surgically menopausal women suffering from FSD by 238 percent versus baseline (p<0.0001); this increase also was significant versus placebo (p<0.05). In this study, the effective dose of LibiGel produced testosterone blood levels within the normal range for pre-menopausal women and had a safety profile similar to that observed in the placebo group. In addition, no serious adverse events and no discontinuations due to adverse events occurred in any subject receiving LibiGel. The Phase II clinical trial was a double-blind, placebo-controlled trial, conducted in the United
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to its future operations and products, the timing of anticipated clinical development milestones and regulatory submissions and other statements identified by words such as "anticipates," "expects," "will," "continue," "could," "believes," "intends," "estimates," "may," other words of similar meaning, derivations of such words and the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
Harris D. McKinney, Inc.
Alan Zachary, 312-506-5220
azachary@harrisdmckinney.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com
Consumer Electronic Stock News; Nyxio (OTCBB:NYXO) Announces "Venture" MMV Line of Virtual Video Display Eyewear
PORTLAND, OR - October 11, 2011 (Investorideas.com Tech stocks newswire) - Nyxio Technologies Corporation (OTC.BB: NYXO.PK) ("Nyxio" or the "Company"), a leading provider of cutting edge "Smart TV" and consumer electronics devices, is very pleased to announce the "Venture" Mobile Media Viewer ("MMV") to its growing product lineup.
The Venture MMV is a new class of video eyewear offering designer styling in a sleek, ergonomic form with unparalleled features and performance. The slim profile and cinematic view screen ensure a state of the art, fantastic wireless viewing experience that is compatible with most video and audio formats.
The Nyxio® Venture MMV now makes it possible to watch your favorite movies, read e-books and play your favorite video games, all in the privacy of your own virtual movie theater, in crystal clear high-resolution and superb sound quality. The USB interface allows easy and high speed file uploading of all your favorite media to a 16:9 wide screen virtual display in a non-radiation LCD panel. The MMV offers built-in 2-4 GB flash memory and up to 32 GB with a micro SD slot for mega media storage.
"These high tech glasses deliver crisp, clear images, complemented by dynamic quality stereo sound effects for the best in style, performance and versatility," states Giorgio Johnson, founder and CEO of Nyxio. "They are perfect for travel and leisure, and the lightweight design allows for long use in total comfort for the ultimate big screen mobile viewing experience."
Designed for cross-functionality with most video display devices, the Venture MMV complements and enriches the viewer's experience dramatically. The Venture is offered as an enhancement to Nyxio's other currently available technologies, including the flagship VioSphere TruSmart TV system, the Realm all-in-one PC/TV and the OMEGA Tablet PC line.
Additional details regarding the Company, its business and its agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information visit: www.nyxio.com.
About Nyxio Technologies
Nyxio Technologies was established in 2007 to deliver high-quality, cutting-edge products to the consumer electronics industry. Nyxio identifies gaps in the market and develops creative products to fill those voids, such as the world�s first integrated flat screen TV and full PC, the VioSphere Smart TV. In addition, by consolidating key hardware into more efficient devices, Nyxio not only reduces the overall environmental footprint of end users, but keeps products reasonably priced. Headquartered in Portland, OR, Nyxio Technologies is a publicly traded company (NYXO) with more than 20 knowledgeable employees.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the UnitedStates Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Contact:
Nyxio
Investor Relations
Summit IR Services, Inc.
Phone: 1-855-436-6996
investors@nyxiotech.com
MEDIA CONTACT
Angie Galimanis
503-546-7871
angie@lanepr.com
PORTLAND, OR - October 11, 2011 (Investorideas.com Tech stocks newswire) - Nyxio Technologies Corporation (OTC.BB: NYXO.PK) ("Nyxio" or the "Company"), a leading provider of cutting edge "Smart TV" and consumer electronics devices, is very pleased to announce the "Venture" Mobile Media Viewer ("MMV") to its growing product lineup.
The Venture MMV is a new class of video eyewear offering designer styling in a sleek, ergonomic form with unparalleled features and performance. The slim profile and cinematic view screen ensure a state of the art, fantastic wireless viewing experience that is compatible with most video and audio formats.
The Nyxio® Venture MMV now makes it possible to watch your favorite movies, read e-books and play your favorite video games, all in the privacy of your own virtual movie theater, in crystal clear high-resolution and superb sound quality. The USB interface allows easy and high speed file uploading of all your favorite media to a 16:9 wide screen virtual display in a non-radiation LCD panel. The MMV offers built-in 2-4 GB flash memory and up to 32 GB with a micro SD slot for mega media storage.
"These high tech glasses deliver crisp, clear images, complemented by dynamic quality stereo sound effects for the best in style, performance and versatility," states Giorgio Johnson, founder and CEO of Nyxio. "They are perfect for travel and leisure, and the lightweight design allows for long use in total comfort for the ultimate big screen mobile viewing experience."
Designed for cross-functionality with most video display devices, the Venture MMV complements and enriches the viewer's experience dramatically. The Venture is offered as an enhancement to Nyxio's other currently available technologies, including the flagship VioSphere TruSmart TV system, the Realm all-in-one PC/TV and the OMEGA Tablet PC line.
Additional details regarding the Company, its business and its agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information visit: www.nyxio.com.
About Nyxio Technologies
Nyxio Technologies was established in 2007 to deliver high-quality, cutting-edge products to the consumer electronics industry. Nyxio identifies gaps in the market and develops creative products to fill those voids, such as the world�s first integrated flat screen TV and full PC, the VioSphere Smart TV. In addition, by consolidating key hardware into more efficient devices, Nyxio not only reduces the overall environmental footprint of end users, but keeps products reasonably priced. Headquartered in Portland, OR, Nyxio Technologies is a publicly traded company (NYXO) with more than 20 knowledgeable employees.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United
Contact:
Nyxio
Investor Relations
Summit IR Services, Inc.
Phone: 1-855-436-6996
investors@nyxiotech.com
MEDIA CONTACT
Angie Galimanis
503-546-7871
angie@lanepr.com
NYXIO TECH CORP (OTC: NYXO) is a showcase stock on Investorideas.com
Visit the company showcase profile page at www.investorideas.com/CO/NYXO
Get News and stock alerts for NYXO - Sign up here
Disclosure: NYXO is a showcase stock on Investorideas.com and the site is compensated three thousand per per month, third party, starting August 1, 2011
Subscribe to:
Posts (Atom)